Chris Schelling Acer Therapeutics Inc. (ACER) insider trading activity
Chris Schelling is PRESIDENT AND CEO of Acer Therapeutics Inc.. Currently has a direct ownership of 0 shares of ACER, which is worth approximately $0. The most recent transaction as insider was on Nov 17, 2023, when has been sold 2,712,529 shares (Common Stock, $0.0001 par value per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
100.0%
12M change
Total Value Held
$0
Chris Schelling Transaction History
CS
Chris Schelling
PRESIDENT AND CEO
Newton, MA